KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is explaining why a medication received regulatory
approval before it became available for routine patient use.
Which statement best describes the primary purpose of large
phase III clinical trials?
A. To determine the chemical structure of the medication
B. To evaluate safety and effectiveness in a large population
before widespread use
C. To identify drug targets using laboratory experiments
D. To monitor rare adverse reactions after the medication is
marketed
Correct Answer: B
Rationale:
Phase III clinical trials evaluate the safety and effectiveness of a
medication in a large group of participants before regulatory
approval is considered. These studies help determine whether
the benefits outweigh the risks in the intended patient
population. Option A occurs during drug discovery. Option C is
part of preclinical research. Option D describes post-marketing
surveillance conducted after approval.
Question 2
,A nurse is reviewing a newly prescribed medication with a
patient. Which concept best describes pharmacodynamics?
A. How the body absorbs, distributes, metabolizes, and
eliminates a drug
B. How a drug produces its therapeutic and adverse effects
within the body
C. The financial cost associated with medication therapy
D. The legal process required for medication approval
Correct Answer: B
Rationale:
Pharmacodynamics focuses on what the drug does to the body,
including its mechanism of action, therapeutic effects, and
adverse effects. Option A describes pharmacokinetics. Options
C and D are unrelated to pharmacodynamic principles.
Question 3
A patient with impaired liver function asks why medication
doses sometimes need adjustment. Which explanation by the
nurse is most appropriate?
A. Liver dysfunction may reduce drug metabolism, increasing
the risk of toxicity.
B. Liver disease prevents medications from entering the
bloodstream.
, C. Liver impairment always decreases medication absorption.
D. Liver disease eliminates the need for therapeutic drug
monitoring.
Correct Answer: A
Rationale:
Many medications undergo hepatic metabolism. Impaired liver
function can slow metabolism, allowing drug concentrations to
accumulate and increasing toxicity risk. Liver disease does not
necessarily impair absorption (Option C), prevent drug entry
into the bloodstream (Option B), or eliminate the need for
monitoring (Option D).
Question 4
A nurse administers an oral medication. Which pharmacokinetic
process refers to the movement of the drug from the
gastrointestinal tract into the systemic circulation?
A. Distribution
B. Elimination
C. Absorption
D. Metabolism
Correct Answer: C
Rationale:
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is explaining why a medication received regulatory
approval before it became available for routine patient use.
Which statement best describes the primary purpose of large
phase III clinical trials?
A. To determine the chemical structure of the medication
B. To evaluate safety and effectiveness in a large population
before widespread use
C. To identify drug targets using laboratory experiments
D. To monitor rare adverse reactions after the medication is
marketed
Correct Answer: B
Rationale:
Phase III clinical trials evaluate the safety and effectiveness of a
medication in a large group of participants before regulatory
approval is considered. These studies help determine whether
the benefits outweigh the risks in the intended patient
population. Option A occurs during drug discovery. Option C is
part of preclinical research. Option D describes post-marketing
surveillance conducted after approval.
Question 2
,A nurse is reviewing a newly prescribed medication with a
patient. Which concept best describes pharmacodynamics?
A. How the body absorbs, distributes, metabolizes, and
eliminates a drug
B. How a drug produces its therapeutic and adverse effects
within the body
C. The financial cost associated with medication therapy
D. The legal process required for medication approval
Correct Answer: B
Rationale:
Pharmacodynamics focuses on what the drug does to the body,
including its mechanism of action, therapeutic effects, and
adverse effects. Option A describes pharmacokinetics. Options
C and D are unrelated to pharmacodynamic principles.
Question 3
A patient with impaired liver function asks why medication
doses sometimes need adjustment. Which explanation by the
nurse is most appropriate?
A. Liver dysfunction may reduce drug metabolism, increasing
the risk of toxicity.
B. Liver disease prevents medications from entering the
bloodstream.
, C. Liver impairment always decreases medication absorption.
D. Liver disease eliminates the need for therapeutic drug
monitoring.
Correct Answer: A
Rationale:
Many medications undergo hepatic metabolism. Impaired liver
function can slow metabolism, allowing drug concentrations to
accumulate and increasing toxicity risk. Liver disease does not
necessarily impair absorption (Option C), prevent drug entry
into the bloodstream (Option B), or eliminate the need for
monitoring (Option D).
Question 4
A nurse administers an oral medication. Which pharmacokinetic
process refers to the movement of the drug from the
gastrointestinal tract into the systemic circulation?
A. Distribution
B. Elimination
C. Absorption
D. Metabolism
Correct Answer: C
Rationale:
